W ithin the Nursing and Midwifery Council's (NMC's) (2008) standards of conduct, performance, and ethics for nurses and midwives, it is stated that, as nurse practitioners, you should make the care of people your first concern, treating them as individuals and respecting their dignity. However, within the author's area of practice, inconsistencies are often evident for those diagnosed with personality disorder.
The Mental Health Foundation (2012) suggests that personality disorders affect how a person thinks and behaves, making it hard for them to live a normal life. They are deep rooted and therefore hard to treat. In addition, the complex behavioural patterns associated with this diagnosis (self harming, substance misuse, avoidance, inability to sustain relationships) have often resulted in frustration and poor therapeutic relationships with providers of health and social care (Mays, 2011) .
The National Institute for Health and Clinical Excellence (NICE) (2009), within its clinical guidelines on the management of borderline personality disorder, advises that drug treatments should not be used for the treatment of the individual symptoms or behaviour associated with this disorder. However, medication continues to be prescribed, despite the fact that almost all research investigating the treatment of personality disorders remains somewhat in its infancy, with the majority of trials undertaken on patients diagnosed with cluster B disorders (emotional, dramatic, erratic behaviors) rather than disorders classed as cluster A (odd or eccentric behaviors) or Cluster C (anxious or fearful behaviors).
Since the introduction of nurse-led clinics within the local area, the author has assessed several patients diagnosed with personality disorder who have been prescribed psychotropic medication. The author acknowledges that, when treating this disorder, it is difficult to disentangle mental state from personality components, such as depression and other mood disturbance (Castle et al, 2006) .
While there is agreement that some actions are clearly unethical (e.g. prescribing for family members or friends), other dilemmas may provoke conflicting responses (General Medical Council (GMC), 2008) . Therefore, a patient may feel justified in demanding medication for a health problem when the prescriber believes that alternative treatment options may be more efficacious and cost effective (e.g. psychotherapy rather than psychopharmacology) (Layard et al, 2007) .
There is inevitably pressure applied to 'experts' in ethics to supply the 'right' answer. While such an outcome may appear attractive at first sight, it can be argued that the role of ethics, and hence of the ethicist, is to explore the issues that underlie the dilemma rather than to provide a definitive solution. Thus, ethics should be seen as part of the tradition of 'critical reflection on practice' , which most health professionals currently engage in (Edwards, 2009 Placing an emphasis on patient choice, autonomy, empowerment, and the establishment of a therapeutic relationship means focusing care on supporting recovery and building the resilience of people with mental health problems, not just on treating or managing their symptoms (Mental Health Foundation, 2012) .
However, in practice, medication continues to be prescribed in the treatment of personality disorder when it is argued that there is efficacy in the use of conventional antipsychotic medication to reduce cognitive perceptions and for selective serotonin reuptake inhibitors (SSRI's) to treat both affective regulation and impulse control.
In addition, there is a range of anticonvulsants as well as mood stabilisers (including lithium and carbamazepine) that can have some positive effects on mood and behaviour (Taylor et al, 2006; Bazire, 2009; Joint Formulary Committee, 2012) .
The author acknowledges the ethical dilemma on prescribers to 'do something' when faced with individuals in distress. This pressure is difficult to withstand and may lead to unwise prescribing that once commences may be difficult to stop. This has been evident within nurseThe pressure to prescribe for patients with personality disorder Email: paul.inman@rdash.nhs.uk led clinics as patients have historically been assessed by locum doctors who appear to have prescribed medication in response to pressure from the patient, family, care coordinator, or consultant psychiatrist (Courtenay and Griffiths, 2005) .
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This pressure on prescribers may contribute to statistics that highlight the remarkable increase in prescribing within the UK. For example, prescriptions of psychotropic drugs (antidepressants, antipsychotics, anxiolitics or barbiturates) are now prescribed to over 15% of the British population-a rise of 7% within the past 10 years (NHS Information Centre for Health and Social Care, 2011).
Other issues can influence prescribers to prescribe such as maintaining the stereotypical view of the doctor, peer, and senior colleague pressure, a lack of time, fear of antagonising the patient, a need to legitimise the patient's illness, or the feeling that not issuing a prescription has somehow let the patient down. Whatever the reason, all current and future prescribers have a duty of care to provide patients with the best available evidenced-based care, and any prescription should be issued to do good rather than to appease and requires thought and the exercise of professional judgment (Stivers, 2007; NMC, 2008) .
It can be argued that the absence of evidence in published research data does not provide the prescriber with an evidence base, and improvements in the patents mood or function are often observed through ongoing assessment or the testimony of the patient or others. Ethically and morally it is wrong to prescribe any medication that has no significant benefit or does harm to the patient. Yet various authors, such as Healey (2004) and Moncrieff and Kirsch (2005) , continue to question the validity, efficacy, and safety of prescribing psychotropic medications for mental health disorders.
The GMC (2008), within its good practice in prescribing medicines document, clearly states that you should only prescribe drugs to meet the identified needs of patients and never simply because patients demand them. Despite these guidelines, the prescribing and administering of medication continues within this patient group. The duty to do good has always been central to the role of the health professional; it is a dynamic process that actively seeks out the most appropriate treatment for the patient. Therefore, beneficence is underpinned by regular professional updating and regular clinical supervision so that the most effective therapies can be discussed and prescribed in partnership with the patient (Edwards, 2009 ).
